Tompkins Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-500
| Closed | -$49.4K | – | 600 |
|
|
2024
Q3 | $49.4K | Hold |
500
| – | – | ﹤0.01% | 339 |
|
|
2024
Q2 | $46.4K | Sell |
500
-100
| -17% | -$9.27K | ﹤0.01% | 348 |
|
|
2024
Q1 | $56.9K | Buy |
600
+100
| +20% | +$9.49K | 0.01% | 335 |
|
|
2023
Q4 | $44.6K | Hold |
500
| – | – | 0.01% | 351 |
|
|
2023
Q3 | $36.5K | Sell |
500
-200
| -29% | -$14.6K | 0.01% | 348 |
|
|
2023
Q2 | $58.2K | Hold |
700
| – | – | 0.01% | 318 |
|
|
2023
Q1 | $53.3K | Hold |
700
| – | – | 0.01% | 329 |
|
|
2022
Q4 | $58K | Buy |
700
+100
| +17% | +$8.29K | 0.01% | 320 |
|
|
2022
Q3 | $48K | Hold |
600
| – | – | 0.01% | 333 |
|
|
2022
Q2 | $45K | Hold |
600
| – | – | 0.01% | 338 |
|
|
2022
Q1 | $54K | Buy |
+600
| New | +$54K | 0.01% | 343 |
|
|
2019
Q3 | – | Sell |
-170
| Closed | -$15K | – | 359 |
|
|
2019
Q2 | $15K | Hold |
170
| – | – | ﹤0.01% | 313 |
|
|
2019
Q1 | $15K | Buy |
+170
| New | +$15K | ﹤0.01% | 331 |
|